Change Language
English - Change Language
Recent Updates
  • Continuous Manufacturing Market by Roots Analysis

    To request sample pages, please visit this - https://www.rootsanalysis.com/reports/308/request-sample.html
    Continuous Manufacturing Market by Roots Analysis To request sample pages, please visit this - https://www.rootsanalysis.com/reports/308/request-sample.html
    Request Sample - Continuous Manufacturing Market (Small Molecules and Biologics) | Industry Analysis | Market Size | 2030
    Market research report on pharmaceutical continuous manufacturing; with a focus on current landscape, key players and future growth opportunities
    0 Comments 0 Shares
  • TIL-based Therapies Market by Roots Analysis

    To request for sample report - https://www.rootsanalysis.com/reports/til-therapies-market/request-sample.html
    TIL-based Therapies Market by Roots Analysis To request for sample report - https://www.rootsanalysis.com/reports/til-therapies-market/request-sample.html
    Request Sample - TIL-based Therapies Market 2021-2030 | Industry Analysis | Market Size | 2030
    TIL-based Therapies Market report features an extensive study of the current market landscape and future potential of the...
    0 Comments 0 Shares
  • Polycystic Ovary Syndrome Market by Roots Analysis
    For additional details, please visit 

    https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html or email [email protected]
    Polycystic Ovary Syndrome Market by Roots Analysis For additional details, please visit  https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html or email [email protected]
    WWW.ROOTSANALYSIS.COM
    Polycystic Ovarian Syndrome (PCOS) Market, 2021-2031 | Industry Analysis | Market Size | 2030
    Polycystic Ovarian Syndrome (PCOS) Market report features an extensive study of the current landscape and the likely future potential of single...
    0 Comments 0 Shares
  • Continuous Manufacturing Market by Roots Analysis
    To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
    Continuous Manufacturing Market by Roots Analysis To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
    WWW.ROOTSANALYSIS.COM
    Continuous Manufacturing Market (Small Molecules and Biologics) | Industry Analysis | Market Size | 2030
    Market research report on pharmaceutical continuous manufacturing; with a focus on current landscape, key players and future growth opportunities
    0 Comments 0 Shares
  • Elastomeric Closure Components Market by Roots Analysis
    To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
    Elastomeric Closure Components Market by Roots Analysis To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
    WWW.ROOTSANALYSIS.COM
    Elastomeric Closures Market: Focus on Parenteral Containers | Industry Analysis | Market Size | 2030
    The Market for Elastomeric Closures for Pharmaceutical Packaging (including vial stoppers and vial seals) is Projected to Grow to USD 9.3 Billion by 2030
    0 Comments 0 Shares
  • The vascular disrupting agents market is projected to be worth USD 2 billion by 2030, growing at an annualized rate of over 60%, claims Roots Analysis
    The market is anticipated to grow at a CAGR of over 60%, during the period 2021-2030

    Growth in this domain is anticipated to be driven by the drugs that are being developed for the treatment of non-small cell lung cancer. North America (primarily the US) and Europe are expected to capture around 50% of the market share by 2030, in terms of the sales-based revenues.




    To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/vascular-disrupting-agents-market/request-sample.html             

     
    The vascular disrupting agents market is projected to be worth USD 2 billion by 2030, growing at an annualized rate of over 60%, claims Roots Analysis The market is anticipated to grow at a CAGR of over 60%, during the period 2021-2030 Growth in this domain is anticipated to be driven by the drugs that are being developed for the treatment of non-small cell lung cancer. North America (primarily the US) and Europe are expected to capture around 50% of the market share by 2030, in terms of the sales-based revenues. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/vascular-disrupting-agents-market/request-sample.html               
    Request Sample - Vascular Disrupting Agents Market, 2021-2030 | Industry Analysis | Market Size | 2030
    Vascular Disrupting Agents Market report features an extensive study of the current market landscape and future potential of the...
    0 Comments 0 Shares
  • The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis


    Over time, ~15 cell and gene therapies have been approved across the world. Since transgene delivery into biological producing cell lines, gene modified cell-based therapies and the body, is an indispensable aspect of modern drug / therapy development efforts, high quality vectors are required by both medical researchers, drug developers and manufact7uring service providers, alike. In order to save time and costs, many stakeholders in the cell and gene therapy market have opted to outsource their vector manufacturing needs.

     

    To order this 685+ page report, which features 170+ figures and 290+ tables, please visit https://www.rootsanalysis.com/reports/view_document/viral-vectors-non-viral-vectors-and-gene-therapy-manufacturing-market-/274.html
    The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis Over time, ~15 cell and gene therapies have been approved across the world. Since transgene delivery into biological producing cell lines, gene modified cell-based therapies and the body, is an indispensable aspect of modern drug / therapy development efforts, high quality vectors are required by both medical researchers, drug developers and manufact7uring service providers, alike. In order to save time and costs, many stakeholders in the cell and gene therapy market have opted to outsource their vector manufacturing needs.   To order this 685+ page report, which features 170+ figures and 290+ tables, please visit https://www.rootsanalysis.com/reports/view_document/viral-vectors-non-viral-vectors-and-gene-therapy-manufacturing-market-/274.html
    WWW.ROOTSANALYSIS.COM
    Viral Vectors Non-Viral Vectors and Gene Therapy Manufacturing Market| Industry Analysis | Market Size | 2030
    The viral vector and gene therapy market, is projected to be worth more than USD 2 Billion by 2030 Growing at an Annualized Rate of Over 20%
    0 Comments 0 Shares
  • The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
    Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

    To order this 330+ page report, which features 130+ figures and 145+ tables, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

    Key Market Insights
     More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are 25+ technology platforms available for use in therapy development efforts




    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    [email protected]
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030 Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 330+ page report, which features 130+ figures and 145+ tables, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html Key Market Insights  More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are 25+ technology platforms available for use in therapy development efforts About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 [email protected] Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Targeted Protein Degradation Market | Industry Analysis | Market Size | 2030
    Research report on the future opportunity of targeted protein degradation therapeutics and technology platforms
    0 Comments 0 Shares
  • The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

    Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
     An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters
     A detailed assessment of the current market landscape of BBB penetrant drugs.
     Identification of contemporary market trends, depicted using three schematic representations, which include [A] a tree map representation, [B] a bubble analysis and [C] an informative heptagon representation.
     An insightful competitiveness analysis of BBB penetration technologies, taking into consideration the supplier power and key technology specific information.
     Elaborate profiles of prominent technology developers that are engaged in the development of at least four drugs.
     An analysis of the partnerships that have been established in the domain, in the period between 2014 and 2020.
     An elaborate discussion on the deal structures of various types of technology licensing agreements inked in this domain.
     An analysis of the investments made in the domain, in the period between 2014 and 2020 (till March).
     An in-depth analysis of the various patents that have been filed / granted related to BBB penetration technologies, till November 2019.
     An insightful chessboard analysis highlighting the most preferred / popular drug development strategies / paths adopted by majority of the drug developers (with clinical candidates) in order to progress their lead drug candidates.
     An assessment of the most commonly targeted disorders affecting the CNS, shortlisted on the basis of number of BBB penetrant drugs in development.
     A list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s disease that are likely to partner with BBB penetration technology providers.
     A case study highlighting the working principle of the most common approaches that are being employed for the development of BBB penetration technologies.
     An informative analysis of contemporary Google Trends in the time period between 2015 and 2019 (till December) and insights generated from recent news articles related to the BBB, indicating the increasing popularity of this domain.
    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) :
     Type of Payment Model Adopted
     Upfront payments
     Milestone payments

     Type of Molecule
     Small Molecules
     Biologics

     Target Disease Indication
     Brain Metastases in Breast Cancer
     Glioblastoma Multiforme
     Hunter Syndrome
     Hurler Syndrome

     Leading Technology Platforms
     G®-Technology
     J-Brain Cargo® Technology
     LRP-1 Technology
     Trojan Horse Technology

     Leading Drug Developers
     2-BBB
     Angiochem
     ArmaGen
     JCR Pharmaceuticals

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific


    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    [email protected]
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:  An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters  A detailed assessment of the current market landscape of BBB penetrant drugs.  Identification of contemporary market trends, depicted using three schematic representations, which include [A] a tree map representation, [B] a bubble analysis and [C] an informative heptagon representation.  An insightful competitiveness analysis of BBB penetration technologies, taking into consideration the supplier power and key technology specific information.  Elaborate profiles of prominent technology developers that are engaged in the development of at least four drugs.  An analysis of the partnerships that have been established in the domain, in the period between 2014 and 2020.  An elaborate discussion on the deal structures of various types of technology licensing agreements inked in this domain.  An analysis of the investments made in the domain, in the period between 2014 and 2020 (till March).  An in-depth analysis of the various patents that have been filed / granted related to BBB penetration technologies, till November 2019.  An insightful chessboard analysis highlighting the most preferred / popular drug development strategies / paths adopted by majority of the drug developers (with clinical candidates) in order to progress their lead drug candidates.  An assessment of the most commonly targeted disorders affecting the CNS, shortlisted on the basis of number of BBB penetrant drugs in development.  A list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s disease that are likely to partner with BBB penetration technology providers.  A case study highlighting the working principle of the most common approaches that are being employed for the development of BBB penetration technologies.  An informative analysis of contemporary Google Trends in the time period between 2015 and 2019 (till December) and insights generated from recent news articles related to the BBB, indicating the increasing popularity of this domain. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) :  Type of Payment Model Adopted  Upfront payments  Milestone payments  Type of Molecule  Small Molecules  Biologics  Target Disease Indication  Brain Metastases in Breast Cancer  Glioblastoma Multiforme  Hunter Syndrome  Hurler Syndrome  Leading Technology Platforms  G®-Technology  J-Brain Cargo® Technology  LRP-1 Technology  Trojan Horse Technology  Leading Drug Developers  2-BBB  Angiochem  ArmaGen  JCR Pharmaceuticals  Key Geographical Regions  North America  Europe  Asia-Pacific Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 [email protected] Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Blood-Brain Barrier (BBB) | Industry Analysis | Market Size | 2030
    Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics Nanoparticle based Approaches)
    0 Comments 0 Shares
  • The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis
    The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.”

    The report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:
     A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes
     Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.
     An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters
     An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research.
     An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength.
     A detailed demand and supply assessment of geographies in this domain.
     An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers.
     A discussion on the potential growth areas in this domain.
     A review of the landscape of prefilled syringe manufacturers.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Scale of Operation
     Preclinical / Clinical
     Commercial
     Type of Drug Molecule
     Biologic
     Small Molecule
     Target Therapeutic Area
     Blood Disorders
     Infectious Diseases
     Metabolic Disorders
     Oncological Disorders
     Neurological Disorders
     Autoimmune Disorders
     Others
     Syringe Barrel Material
     Glass
     Plastic
     Number of Barrel Chambers
     Single Chamber
     Dual Chamber
     Key Geographical Region
     North America
     Europe
     Latin America
     Asia-Pacific
     Middle East and Africa

    Key companies covered in the report
     Ajinomoto Bio-Pharma Services
     AMRI
     BioPharma Solutions
     Emergent BioSolutions
     Patheon
     Consort Medical
     EVER Pharma
     GlaxoSmithKline
     IDT Biologika
     Rentschler Biopharma
     Siegfried
     Vetter Pharma
     Biocon
     Intas Pharmaceuticals
     Kemwell Biopharma
     Square Pharmaceuticals

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

    Other Recent Offerings
    1. Prefilled Syringes Market (5th Edition), 2020-2030
    2. Biologics Fill / Finish Services Market, 2019-2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    [email protected]
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:  A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes  Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.  An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters  An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research.  An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength.  A detailed demand and supply assessment of geographies in this domain.  An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers.  A discussion on the potential growth areas in this domain.  A review of the landscape of prefilled syringe manufacturers.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Scale of Operation  Preclinical / Clinical  Commercial  Type of Drug Molecule  Biologic  Small Molecule  Target Therapeutic Area  Blood Disorders  Infectious Diseases  Metabolic Disorders  Oncological Disorders  Neurological Disorders  Autoimmune Disorders  Others  Syringe Barrel Material  Glass  Plastic  Number of Barrel Chambers  Single Chamber  Dual Chamber  Key Geographical Region  North America  Europe  Latin America  Asia-Pacific  Middle East and Africa Key companies covered in the report  Ajinomoto Bio-Pharma Services  AMRI  BioPharma Solutions  Emergent BioSolutions  Patheon  Consort Medical  EVER Pharma  GlaxoSmithKline  IDT Biologika  Rentschler Biopharma  Siegfried  Vetter Pharma  Biocon  Intas Pharmaceuticals  Kemwell Biopharma  Square Pharmaceuticals For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html Other Recent Offerings 1. Prefilled Syringes Market (5th Edition), 2020-2030 2. Biologics Fill / Finish Services Market, 2019-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 [email protected] Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Prefilled Syringe Fill / Finish Services | Industry Analysis | Market Size | 2030
    Market research report on prefilled syringe (PFS) fill / finish services; with a focus on current market landscape and future growth opportunities
    0 Comments 0 Shares
More Stories